Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
65.26 USD | +0.11% | -0.99% | +4.69% |
08/05 | Vaxcyte, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
25/04 | Vaxcyte Insider Sold Shares Worth $928,845, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.69% | 709.24Cr | |
+4.58% | 11TCr | |
+11.58% | 11TCr | |
+0.58% | 2.23TCr | |
-11.56% | 2.21TCr | |
-7.63% | 1.87TCr | |
-38.36% | 1.76TCr | |
-10.50% | 1.69TCr | |
+4.61% | 1.38TCr | |
+36.78% | 1.25TCr |
- Stock Market
- Equities
- PCVX Stock
- News Vaxcyte, Inc.
- Vaxcyte Insider Sold Shares Worth $828,915, According to a Recent SEC Filing